biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Pisemne sprawozdanie Rady Nadzorczej Scope Fluidics S.A. na 30 czerwca 2022

Previous PostNext Post

Related Posts

08.09.2026

Scope Fluidics Secures Another U.S. Patent for the BACTEROMIC System

0
07.07.2026

Scope Fluidics signs agreement for distribution of the BACTEROMIC system in 10 European markets

0
01.07.2026

Scope Fluidics Signs Agreement for Clinical Trials of the BACTEROMIC System PBC Panel

0